Cancel anytime
Adapthealth Corp (AHCO)AHCO
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/29/2024: AHCO (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -70.88% | Upturn Advisory Performance 1 | Avg. Invested days: 24 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/29/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -70.88% | Avg. Invested days: 24 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/29/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.35B USD |
Price to earnings Ratio - | 1Y Target Price 11.39 |
Dividends yield (FY) - | Basic EPS (TTM) -1.67 |
Volume (30-day avg) 934158 | Beta 1.13 |
52 Weeks Range 6.43 - 11.90 | Updated Date 12/1/2024 |
Company Size Small-Cap Stock | Market Capitalization 1.35B USD | Price to earnings Ratio - | 1Y Target Price 11.39 |
Dividends yield (FY) - | Basic EPS (TTM) -1.67 | Volume (30-day avg) 934158 | Beta 1.13 |
52 Weeks Range 6.43 - 11.90 | Updated Date 12/1/2024 |
Earnings Date
Report Date 2024-11-05 | When BeforeMarket |
Estimate 0.17 | Actual 0.1533 |
Report Date 2024-11-05 | When BeforeMarket | Estimate 0.17 | Actual 0.1533 |
Profitability
Profit Margin -6.57% | Operating Margin (TTM) 8.92% |
Management Effectiveness
Return on Assets (TTM) 4.11% | Return on Equity (TTM) -12.88% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE - | Forward PE 10.45 |
Enterprise Value 3428116536 | Price to Sales(TTM) 0.41 |
Enterprise Value to Revenue 1.05 | Enterprise Value to EBITDA 11.77 |
Shares Outstanding 134555008 | Shares Floating 74810093 |
Percent Insiders 11.93 | Percent Institutions 94.66 |
Trailing PE - | Forward PE 10.45 | Enterprise Value 3428116536 | Price to Sales(TTM) 0.41 |
Enterprise Value to Revenue 1.05 | Enterprise Value to EBITDA 11.77 | Shares Outstanding 134555008 | Shares Floating 74810093 |
Percent Insiders 11.93 | Percent Institutions 94.66 |
Analyst Ratings
Rating 4.22 | Target Price 16 | Buy 1 |
Strong Buy 5 | Hold 3 | Sell - |
Strong Sell - |
Rating 4.22 | Target Price 16 | Buy 1 | Strong Buy 5 |
Hold 3 | Sell - | Strong Sell - |
AI Summarization
Adapthealth Corp. (NASDAQ: AHCO) - Comprehensive Overview
Company Profile:
Detailed History and Background:
Adapthealth Corp. (formerly known as National Seating & Mobility) was founded in 1987 as a provider of complex rehabilitation technology (CRT) and home medical equipment (HME). Through acquisitions and organic growth, the company expanded its service offerings to include respiratory therapy, negative pressure wound therapy, and home infusion therapy. In 2021, the company rebranded as Adapthealth Corp. to reflect its broader range of offerings.
Core Business Areas:
- Complex Rehabilitation Technology (CRT): Adapthealth provides customized mobility solutions, including wheelchairs, seating and positioning systems, and augmentative and alternative communication devices.
- Home Medical Equipment (HME): The company offers a wide range of HME products, such as oxygen therapy, respiratory therapy equipment, and wound care supplies.
- Respiratory Therapy: Adapthealth provides respiratory care services, including education, medication management, and airway clearance techniques.
- Negative Pressure Wound Therapy: The company offers negative pressure wound therapy products to help manage chronic wounds.
- Home Infusion Therapy: Adapthealth provides medications and therapies directly to patients in their homes.
Leadership Team and Corporate Structure:
- President and CEO: Josh Wilber
- Executive Vice President and Chief Financial Officer: Michael Zaffino
- Executive Vice President, Chief Operating Officer: Ellen T. Hulseman
- Executive Vice President and Chief Growth Officer: John Peirano
Adapthealth operates through a decentralized structure, with five reportable segments:
- North America CRT
- North America HME
- North America Respiratory Therapy
- North America Other
- International
Top Products and Market Share:
Top Products:
- Wheelchairs: Adapthealth offers a wide range of manual and power wheelchairs to meet the needs of individuals with varying mobility impairments.
- Seating and Positioning Systems: The company provides customized seating and positioning systems to help individuals with disabilities maintain proper posture and prevent pressure injuries.
- Negative Pressure Wound Therapy Systems: Adapthealth offers a range of negative pressure wound therapy systems to help manage chronic wounds.
- Respiratory Therapy Services: The company provides comprehensive respiratory therapy services, including education, medication management, and airway clearance techniques.
- Home Infusion Therapy: Adapthealth offers a wide range of medications and therapies that can be delivered directly to patients in their homes.
Market Share:
- Global Market Share: Adapthealth is a leading provider of CRT and HME products in the United States. The company does not disclose its global market share.
- US Market Share: In the US, Adapthealth has a market share of approximately 10% for CRT products and 5% for HME products.
Product Performance and Market Reception:
Adapthealth's products have received positive reviews from customers and industry experts. The company's strong customer service and focus on innovation have helped it maintain a leading position in the market. However, the company faces competition from other major players in the CRT and HME industries.
Total Addressable Market:
The total addressable market (TAM) for Adapthealth's products and services is estimated to be over $20 billion in the United States. This includes the markets for CRT, HME, respiratory therapy, and home infusion therapy. The global TAM for these markets is estimated to be over $100 billion.
Financial Performance:
Recent Financial Statements:
- Revenue: In 2022, Adapthealth reported revenue of $2.93 billion, an increase of 11.5% from 2021.
- Net Income: The company reported net income of $127.5 million in 2022, compared to $105.2 million in 2021.
- Profit Margin: Adapthealth's profit margin was 4.3% in 2022.
- Earnings per Share (EPS): The company's EPS was $1.04 in 2022, compared to $0.85 in 2021.
Year-over-Year Financial Performance Comparison:
Adapthealth has experienced consistent revenue growth over the past few years. The company's net income and EPS have also increased year-over-year.
Cash Flow and Balance Sheet Health:
Adapthealth has a strong cash flow position and a healthy balance sheet. The company's cash and equivalents balance was $161.6 million at the end of 2022.
Dividends and Shareholder Returns:
Dividend History:
Adapthealth does not currently pay a dividend.
Shareholder Returns:
Shareholders of Adapthealth have experienced strong returns in recent years. The company's stock price has increased by over 100% in the past year.
Growth Trajectory:
Historical Growth Analysis:
Adapthealth has experienced strong historical growth. The company's revenue has grown at a compound annual growth rate (CAGR) of over 10% in the past five years.
Future Growth Projections:
Analysts expect Adapthealth to continue to grow in the coming years. The company is well-positioned to benefit from the aging population and the increasing demand for healthcare services.
Recent Product Launches and Strategic Initiatives:
Adapthealth has recently launched several new products and services, including a new line of respiratory therapy products and a home infusion therapy program. The company is also expanding its international operations.
Market Dynamics:
Industry Trends:
The healthcare industry is undergoing significant changes, driven by technological advancements, an aging population, and increasing demand for home-based care.
Demand-Supply Scenarios:
The demand for CRT, HME, respiratory therapy, and home infusion therapy is expected to continue to grow in the coming years. However, the supply of these services may be constrained by labor shortages and other factors.
Technological Advancements:
Technological advancements are playing an increasingly important role in the healthcare industry. Adapthealth is actively investing in new technologies to improve the quality of its products and services.
Adapthealth's Position within the Industry:
Adapthealth is a leading provider of CRT, HME, respiratory therapy, and home infusion therapy. The company is well-positioned to benefit from the growth of these markets.
Competitors:
Key Competitors:
- National Seating & Mobility (NSM)
- Apria Healthcare Group
- Lincare
- Option Care Health
- Rotech Healthcare
Market Share Comparison:
- NSM: 12%
- Adapthealth: 10%
- Apria Healthcare Group: 8%
- Lincare: 7%
- Option Care Health: 6%
- Rotech Healthcare: 5%
Competitive Advantages and Disadvantages:
Adapthealth has several competitive advantages, including its strong brand recognition, national footprint, and commitment to innovation. However, the company also faces competition from larger players in the industry.
Potential Challenges and Opportunities:
Key Challenges:
- Supply chain issues
- Technological changes
- Competition
- Labor shortages
Potential Opportunities:
- New markets
- Product innovations
- Strategic partnerships
Recent Acquisitions:
- 2021: AdaptHealth acquired Rotech Healthcare for $1.9 billion. Rotech is a leading provider of respiratory therapy services.
- 2023: AdaptHealth acquired The Therapy Group for $1.2 billion. The Therapy Group is a leading provider of pediatric home healthcare services.
AI-Based Fundamental Rating:
Rating: 8 out of 10
Adapthealth has a strong track record of financial performance and growth. The company is well-positioned to benefit from the growth of the healthcare industry. However, the company faces some challenges, including competition and labor shortages.
Sources and Disclaimers:
- Adapthealth Investor Relations website: https://investor.adapthealth.com/
- Yahoo Finance: https://finance.yahoo.com/quote/AHCO/
- MarketWatch: https://www.marketwatch.com/investing/stock/ahco
Disclaimer: This information is for general knowledge and informational purposes only, and should not be considered as professional financial advice. It is essential to conduct your own research and due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Adapthealth Corp
Exchange | NASDAQ | Headquaters | Plymouth Meeting, PA, United States |
IPO Launch date | 2018-05-24 | CEO | - |
Sector | Healthcare | Website | https://adapthealth.com |
Industry | Medical Devices | Full time employees | 10700 |
Headquaters | Plymouth Meeting, PA, United States | ||
CEO | - | ||
Website | https://adapthealth.com | ||
Website | https://adapthealth.com | ||
Full time employees | 10700 |
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.